Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
JD.com, Inc. · JD · FY2024 Q2 · Calendar Q3 2024
The supplied analysis supports a mixed but constructive operating picture: supply-chain efficiency, user growth, supermarket momentum, and 3P expansion supported profitability, while modest revenue growth and competitive, subsidy, and monetization risks temper the outlook.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Profitability improved to a reported record in the supplied Q2 2024 analysis, while revenue growth stayed modest. The analysis also emphasizes accelerating 3P order volume, broader trade-in support, and a greater focus on advertising monetization versus the prior quarter.
Maintained; the supplied analysis does not identify a change in guidance.
Follow JD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Oct 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 13, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Aug 17, 2026 |
| Daiwa Capital | Hold | Buy | Downgrade | Jun 24, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 13, 2026 |
| Benchmark | Buy | Buy | Maintain | May 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 14, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Jan 7, 2026 |
| UBS | Buy | Buy | Maintain | Jul 10, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | May 27, 2025 |
| Mizuho | Outperform | Outperform | Maintain | May 14, 2025 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 23, 2025 |
| Loop Capital | Buy | Hold | Upgrade | Oct 21, 2024 |
| HSBC | Buy | Buy | Maintain | Mar 7, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 25, 2023 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jan 11, 2022 |
| DZ Bank | Sell | Buy | Downgrade | Jul 27, 2021 |
| Stifel | Buy | Buy | Maintain | May 12, 2021 |
| CFRA | Buy | Buy | Maintain | May 19, 2020 |
| Nomura | Buy | Buy | Maintain | May 18, 2020 |
| China Renaissance | Buy | Hold | Upgrade | Mar 3, 2020 |
| UOB Kay Hian | Buy | Hold | Upgrade | Nov 18, 2019 |
| Vertical Group | Buy | Buy | Maintain | Oct 22, 2019 |
| 86 Research | Buy | Hold | Upgrade | Oct 11, 2019 |
| Jefferies | Buy | Buy | Maintain | Aug 5, 2019 |
| CICC | Buy | Hold | Upgrade | May 13, 2019 |
| CLSA | Outperform | Underperform | Upgrade | Mar 1, 2019 |
| MKM Partners | Buy | Buy | Maintain | Dec 7, 2018 |
| KeyBanc | Overweight | Downgrade | Oct 29, 2018 | |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 17, 2018 |
| Wells Fargo | Outperform | Outperform | Maintain | Nov 14, 2017 |
| Bank of America | Buy | Neutral | Upgrade | Mar 2, 2017 |
| Evercore ISI Group | Buy | Buy | Maintain | Dec 20, 2016 |
| TH Capital | Hold | Buy | Downgrade | Aug 8, 2016 |
| T.H. Capital | Hold | Buy | Downgrade | Aug 8, 2016 |
| Credit Suisse | Neutral | Outperform | Downgrade | May 10, 2016 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 11, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | May 4, 2015 |
| Summit Research Partners | Hold | Hold | Maintain | Apr 20, 2015 |
| William Blair | Outperform | Market Perform | Upgrade | Mar 17, 2015 |
| Deutsche Bank | Hold | Hold | Maintain | Oct 30, 2014 |
| Brean Capital | Buy | Buy | Maintain | Sep 10, 2014 |
| PiperJaffray | Neutral | Neutral | Maintain | Jul 1, 2014 |
| Cowen & Co. | Perform | Market Perform | Maintain | Jul 1, 2014 |
Upside is calculated against the persisted current price $25.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $38 | $26.78 | +49.8% | Oct 14, 2026 |
| UBS | Analyst unavailable | $37 | $26.72 | +45.9% | Oct 13, 2026 |
| Arete Research | Analyst unavailable | $30 | $28.26 | +18.3% | Sep 7, 2026 |
| Mizuho Securities | Wei Fang | $39 | $29.3 | +53.8% | Aug 14, 2026 |
| Macquarie | Analyst unavailable | $37 | $28.97 | +45.9% | Jul 13, 2026 |
| Daiwa | Analyst unavailable | $27 | $26.26 | +6.5% | Jun 23, 2026 |
| Susquehanna | Shyam Patil | $35 | $33.16 | +38.0% | May 14, 2026 |
| Barclays | Analyst unavailable | $43 | $33.77 | +69.6% | May 14, 2026 |
| Bernstein | Robin Zhu | $40 | $31.49 | +57.7% | May 13, 2026 |
| Arete Research | Analyst unavailable | $37 | $31.85 | +45.9% | Apr 17, 2026 |
| Bernstein | Robin Zhu | $36 | $31.47 | +42.0% | Apr 16, 2026 |
| Macquarie | Analyst unavailable | $35 | $31.25 | +38.0% | Apr 14, 2026 |
| Susquehanna | Analyst unavailable | $30 | $27.47 | +18.3% | Mar 9, 2026 |
| UBS | Analyst unavailable | $33 | $25.47 | +30.1% | Mar 5, 2026 |
| Morgan Stanley | Eddy Wang | $22 | $25.47 | -13.2% | Mar 5, 2026 |
| Macquarie | Ellie Jiang | $25 | $25.47 | -1.4% | Mar 5, 2026 |
| HSBC | Peishan Wang | $37 | $29.4 | +45.9% | Dec 29, 2025 |
| Arete Research | Analyst unavailable | $32 | $29.92 | +26.2% | Dec 9, 2025 |
| Bernstein | Robin Zhu | $38 | $29.75 | +49.8% | Nov 14, 2025 |
| Mizuho Securities | Wei Fang | $41 | $32.83 | +61.7% | Oct 22, 2025 |
| Arete Research | Analyst unavailable | $41 | $35.17 | +61.7% | Sep 26, 2025 |
| Mizuho Securities | Wei Fang | $48 | $36.05 | +89.3% | May 14, 2025 |
| Morgan Stanley | Eddy Wang | $39 | $37.25 | +53.8% | May 13, 2025 |
| Susquehanna | Analyst unavailable | $45 | $40.37 | +77.4% | Mar 12, 2025 |
| Mizuho Securities | Analyst unavailable | $50 | $42.29 | +97.2% | Mar 7, 2025 |
| UBS | Analyst unavailable | $51 | $42.29 | +101.1% | Mar 7, 2025 |
| Barclays | Analyst unavailable | $55 | $41.9 | +116.9% | Feb 28, 2025 |
| Bernstein | Robin Zhu | $46 | $37.18 | +81.4% | Dec 9, 2024 |
| Loop Capital Markets | Rob Sanderson | $48 | $39.98 | +89.3% | Oct 21, 2024 |
| Jefferies | Thomas Chong | $54 | $43.83 | +112.9% | Oct 14, 2024 |
| Morgan Stanley | Eddy Wang | $28 | $26.54 | +10.4% | Aug 27, 2024 |
| Citigroup | Alicia Yap | $41 | $26.3 | +61.7% | Aug 21, 2024 |
| Citigroup | Alicia Yap | $42 | $27.18 | +65.6% | Aug 15, 2024 |
| Loop Capital Markets | Rob Sanderson | $31 | $28.02 | +22.2% | Jun 21, 2024 |
| Mizuho Securities | James Lee | $40 | $34.27 | +57.7% | May 17, 2024 |
| UBS | Jerry Liu | $40 | $34.27 | +57.7% | May 17, 2024 |
| Barclays | Gregory Zhao | $41 | $34.27 | +61.7% | May 17, 2024 |
| Macquarie | Ellie Jiang | $40 | $34.27 | +57.7% | May 17, 2024 |
| Loop Capital Markets | Rob Sanderson | $35 | $33.69 | +38.0% | May 13, 2024 |
| Morgan Stanley | Eddy Wang | $25 | $25.01 | -1.4% | Apr 19, 2024 |
| Morgan Stanley | Eddy Wang | $27 | $25.48 | +6.5% | Apr 18, 2024 |
| Susquehanna | Shyam Patil | $38 | $33.27 | +49.8% | Aug 31, 2023 |
| Morgan Stanley | Eddy Wang | $55 | $36.96 | +116.9% | Oct 28, 2022 |
| Mizuho Securities | James Lee | $90 | $56.66 | +254.9% | Sep 19, 2022 |
| Morgan Stanley | Eddy Wang | $80 | $51.16 | +215.5% | May 18, 2022 |
| Citigroup | Alicia Yap | $97 | $52.04 | +282.5% | Apr 23, 2022 |
| Morgan Stanley | Eddy Wang | $85 | $58.69 | +235.2% | Mar 8, 2022 |
| Macquarie | Ellie Jiang | $112 | $78.09 | +341.6% | Dec 7, 2021 |
| Susquehanna | Shyam Patil | $95 | $89.36 | +274.6% | Nov 24, 2021 |
| Benchmark Co. | Fawne Jiang | $117 | $91.55 | +361.4% | Nov 19, 2021 |
| CLSA | Elinor Leung | $108 | $91.55 | +325.9% | Nov 19, 2021 |
| Credit Suisse | Kenneth Fong | $120 | $91.55 | +373.2% | Nov 19, 2021 |
| Goldman Sachs | Ronald Keung | $123 | $84.2 | +385.0% | Nov 11, 2021 |
| Loop Capital Markets | Rob Sanderson | $115 | $80.17 | +353.5% | Sep 13, 2021 |
| DZ BANK AG | Manuel Muhl | $62 | $64.77 | +144.5% | Jul 27, 2021 |
| China Renaissance Securities (US) Inc. | Ella Ji | $96 | $74.9 | +278.5% | Jun 24, 2021 |
| Daiwa | John Choi | $110 | $78.12 | +333.8% | Apr 14, 2021 |
Track every rating change on JD the moment it posts. Free to start.
Start freeJD.com, Inc. is a prominent technology and service provider based in the People's Republic of China, distinguished by its robust, supply chain-centric operations. The company's retail segment offers a comprehensive array of products. This includes computing devices, communication equipment, and various consumer electronics, alongside a broad selection of home appliances. Beyond these, JD.com provides an extensive general merchandise category, covering everything from groceries (food, beverages, fresh produce) and daily essentials (baby and maternity items, furniture, household goods, personal care, cosmetics, pharmaceuticals, health products) to specialized goods (industrial products, books, automotive accessories, apparel, footwear, bags, and jewelry).…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DECK Deckers Outdoor Corporation | FY2027 Q2 · Calendar Q4 2026 | +13.4% | -0.2% | Deckers raises FY2027 outlook as HOKA and UGG drive growth |
| TSCO Tractor Supply Company | FY2026 Q3 · Calendar Q4 2026 | +5.3% | +6.2% | Tractor Supply Q3: Pet and Digital Momentum Supports Margin Plan |
| PHM PulteGroup, Inc. | FY2026 Q3 · Calendar Q4 2026 | -4.5% | +5.8% | PulteGroup Holds Guidance as Buyer Traffic Slows |
| PKG Packaging Corporation of America | FY2026 Q3 · Calendar Q4 2026 | +3.8% | +4.2% | PCA beats Q3 expectations as Greif synergies offset cost pressure |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-26. For educational purposes only; not investment advice.